High-dose therapy with stem cell rescue for pediatric solid tumors

Rationale and results

Research output: Contribution to journalArticle

Abstract

Metastatic and recurrent pediatric solid tumors usually respond to chemotherapy but are likely to recur. Because of steep dose response relationships, HDT requiring hematopoietic rescue may improve outcome. This strategy has recently been shown to be effective for metastatic neuroblastoma. Metastatic Ewing's sarcoma appears to be a closely analogous situation, and promising phase II studies suggest that a definitive trial of efficacy would be appropriate. Phase I or II trials remain appropriate and are needed to define further the efficacy of HDT for most other poor prognosis pediatric solid tumors.

Original languageEnglish (US)
Pages (from-to)78-86
Number of pages9
JournalPediatric Transplantation
Volume3
Issue numberSUPPL. 1
DOIs
StatePublished - 1999

Fingerprint

Stem Cells
Pediatrics
Ewing's Sarcoma
Neuroblastoma
Neoplasms
Drug Therapy
Therapeutics

Keywords

  • Bone marrow transplantation
  • Ewing's sarcoma rhabdomyosarcoma
  • Hematopoietic stem cell transplantation
  • Wilms' tumor osteosarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

High-dose therapy with stem cell rescue for pediatric solid tumors : Rationale and results. / Chen, Allen R.

In: Pediatric Transplantation, Vol. 3, No. SUPPL. 1, 1999, p. 78-86.

Research output: Contribution to journalArticle

@article{5f6c78b8420047889ad1d6c460340133,
title = "High-dose therapy with stem cell rescue for pediatric solid tumors: Rationale and results",
abstract = "Metastatic and recurrent pediatric solid tumors usually respond to chemotherapy but are likely to recur. Because of steep dose response relationships, HDT requiring hematopoietic rescue may improve outcome. This strategy has recently been shown to be effective for metastatic neuroblastoma. Metastatic Ewing's sarcoma appears to be a closely analogous situation, and promising phase II studies suggest that a definitive trial of efficacy would be appropriate. Phase I or II trials remain appropriate and are needed to define further the efficacy of HDT for most other poor prognosis pediatric solid tumors.",
keywords = "Bone marrow transplantation, Ewing's sarcoma rhabdomyosarcoma, Hematopoietic stem cell transplantation, Wilms' tumor osteosarcoma",
author = "Chen, {Allen R}",
year = "1999",
doi = "10.1034/j.1399-3046.1999.00053.x",
language = "English (US)",
volume = "3",
pages = "78--86",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - High-dose therapy with stem cell rescue for pediatric solid tumors

T2 - Rationale and results

AU - Chen, Allen R

PY - 1999

Y1 - 1999

N2 - Metastatic and recurrent pediatric solid tumors usually respond to chemotherapy but are likely to recur. Because of steep dose response relationships, HDT requiring hematopoietic rescue may improve outcome. This strategy has recently been shown to be effective for metastatic neuroblastoma. Metastatic Ewing's sarcoma appears to be a closely analogous situation, and promising phase II studies suggest that a definitive trial of efficacy would be appropriate. Phase I or II trials remain appropriate and are needed to define further the efficacy of HDT for most other poor prognosis pediatric solid tumors.

AB - Metastatic and recurrent pediatric solid tumors usually respond to chemotherapy but are likely to recur. Because of steep dose response relationships, HDT requiring hematopoietic rescue may improve outcome. This strategy has recently been shown to be effective for metastatic neuroblastoma. Metastatic Ewing's sarcoma appears to be a closely analogous situation, and promising phase II studies suggest that a definitive trial of efficacy would be appropriate. Phase I or II trials remain appropriate and are needed to define further the efficacy of HDT for most other poor prognosis pediatric solid tumors.

KW - Bone marrow transplantation

KW - Ewing's sarcoma rhabdomyosarcoma

KW - Hematopoietic stem cell transplantation

KW - Wilms' tumor osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0032698443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032698443&partnerID=8YFLogxK

U2 - 10.1034/j.1399-3046.1999.00053.x

DO - 10.1034/j.1399-3046.1999.00053.x

M3 - Article

VL - 3

SP - 78

EP - 86

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - SUPPL. 1

ER -